Status:
ACTIVE_NOT_RECRUITING
ADIE-BC - Aligning Dimensions of Interoceptive Experience in Breast Cancer Survivors
Lead Sponsor:
King's College London
Collaborating Sponsors:
University College, London
Brighton & Sussex Medical School
Conditions:
Cancer
Primary Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A breast cancer diagnosis can lead to significant anxiety, and for many survivors, this anxiety continues well beyond the end of treatment. While standard anxiety therapies are helpful for some, these...
Detailed Description
Anxiety is a common and often long-lasting psychological consequence of a breast cancer diagnosis. Post-cancer anxiety frequently co-occurs with somatic symptoms such as persistent pain and fatigue. F...
Eligibility Criteria
Inclusion
- 18 years old or older
- Residing in the UK and able to travel into London
- Can read and write in English
- Have had a diagnosis of Primary Breast Cancer
- Have completed active, hospital-based treatment for primary breast cancer (Stages 1, 2 or 3; this refers to radiotherapy, surgery, or chemotherapy) 6 months - 10 years previously (this does not apply to ongoing endocrine (hormone) therapy)
Exclusion
- Currently taking medication for cardiac arrhythmia (e.g., beta blockers)
- Currently in active treatment for breast cancer and/or other types of cancer
- Currently pregnant
Key Trial Info
Start Date :
June 13 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06954532
Start Date
June 13 2025
End Date
March 1 2026
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King's College London
London, United Kingdom, SE1 9RT